Welcome to our dedicated page for Stepan SEC filings (Ticker: SCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Stepan Company (NYSE: SCL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the details. As a public issuer in the specialty and intermediate chemicals space, Stepan files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that describe its surfactants, polymers and specialty products businesses, financial results and governance matters.
In Stepan’s 10-K and 10-Q filings, readers can review segment information for surfactants, polymers and specialty products, along with discussions of sales volumes, selling prices, raw material cost pass-through, product mix and operating income. These reports also cover topics such as the company’s global manufacturing footprint in North and South America, Europe and Asia, and its role as a leading merchant producer of surfactants and supplier of polyurethane polyols for thermal insulation and CASE markets.
Form 8-K current reports provide updates on specific events, including quarterly earnings releases, dividend declarations, executive appointments or departures, board changes and adoption of plans such as the Key Executive Severance Benefit Plan. These filings give timely insight into Stepan’s capital allocation, leadership structure and key corporate actions.
Stock Titan enhances access to Stepan’s filings with AI-generated summaries that highlight the most important points in lengthy documents, helping users quickly understand complex financial and legal language. Real-time updates from EDGAR ensure that new Stepan filings appear promptly, while dedicated views for insider transaction reports (Form 4), proxy statements (Schedule 14A) and other forms allow deeper analysis of executive compensation, ownership changes and governance practices. This page serves as a focused resource for anyone researching SCL through its official SEC record.
Stepan Company (NYSE: SCL) filed its Q2-25 Form 10-Q. Net sales rose 6.9% YoY to $594.7 million, driven by 8.3% growth in Surfactants and 1.9% in Polymers; Specialty Products advanced 21.5%. Gross profit improved 3.4% to $71.9 million, but operating income slipped 3.8% to $18.0 million as selling and R&D costs increased 6.0%. Higher interest expense (-106% YoY) cut pre-tax earnings 20% to $13.8 million; however, a sharply lower effective tax rate (17.7% vs. 44.7%) lifted net income 19% to $11.3 million, or $0.50 diluted EPS.
For the six-month period, revenue gained 7.2% to $1.19 billion and operating income rose 19% to $46.3 million. Net income reached $31.1 million (+32.6%), translating to $1.36 EPS.
Segment detail (Q2): Polymers profit jumped 26% to $17.2 million on higher volume and price/mix, offsetting declines in Surfactants (-22%) and Specialty Products (-28%). Corporate expense fell 8%.
Balance sheet: Cash fell to $88.9 million (-$10.8 million YTD) as operating cash flow weakened to $18.1 million from $71.1 million. Capex remained elevated at $58.3 million. Total debt increased 5.3% to $658 million after issuing $75 million of 6.17% senior notes; net leverage stands near 1.1× EBITDA. Equity improved to $1.24 billion, aided by a $57 million favorable FX translation adjustment that reduced AOCI.
Other highlights: • Assets of the Philippine surfactant plant ($8.7 million) classified as held for sale.
• Environmental liabilities accrued at $19.5 million (low end of $19.5–$44.9 million range).
• New U.S. tax act (enacted 7-4-25) not yet reflected; management expects no material 2025 impact.
Outlook: Management continues to invest in capacity (capex $58 million YTD) while navigating higher financing costs and mixed segment margins. Sale of the Philippine site and working-capital normalization are expected to support liquidity in 2H-25.
Form 8-K material event: Stepan Company (NYSE: SCL) disclosed the appointment of Ruben Velasquez, age 51, as Vice President & Chief Financial Officer, effective July 15 2025. He succeeds interim CFO Samuel Hinrichsen, who returns to his prior role as Vice President of Finance.
Professional background: Velasquez joins from 3M Company, where he spent 19 years in progressively senior finance roles, most recently serving as Vice President of Global Finance Transformation (2022-2024). His previous posts at 3M included CFO positions for Manufacturing & Supply Chain Operations (2021-2022), Consumer Business (2016-2021), and Electronics Materials Solutions (2013-2016), as well as country CFO roles in Russia and Colombia.
Compensation: • Base salary: $475,000 per year. • Target annual cash incentive: 75 % of base salary. • Initial long-term incentive grant (Aug-2025): $200,000 in restricted stock units, $100,000 in performance shares, and $100,000 in stock appreciation rights, all with standard performance and vesting terms. • Relocation benefits and standard executive perquisites.
Governance disclosures: The filing notes no relationships or related-party transactions under Item 404(a). Appointment terms are not tied to any arrangement with other parties.
Exhibits: 99.1 – press release dated July 14 2025 announcing the appointment; 104 – cover-page Inline XBRL data file.
This leadership change completes the CFO search and places a seasoned multinational executive at the helm of Stepan’s finance organization.
Stepan Co. (SCL) — Form 3 initial insider filing: On 06/20/2025, attorney-in-fact James A. Hart submitted an Initial Statement of Beneficial Ownership on behalf of director Corning F. Painter, covering the event date 06/09/2025.
The filing establishes Painter’s baseline insider status and confirms that he currently owns no direct or indirect shares or derivative securities of Stepan Co. Going forward, any purchase or disposition by the director must be reported on Form 4 within two business days. The disclosure is routine and contains no financial metrics or transactional details that would alter Stepan’s investment outlook.